- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: tiragolumab
Total 58 results
-
The Netherlands Cancer InstituteHoffmann-La RocheNot yet recruiting
-
National Cancer Institute (NCI)Not yet recruitingRecurrent Glioblastoma, IDH-Wildtype
-
Hoffmann-La RocheRecruitingNon-small Cell Lung Cancer (NSCLC)Korea, Republic of, United States, China, Australia, Taiwan, Brazil, Japan, Argentina
-
Institut CurieHoffmann-La RocheRecruitingTriple Negative Breast CancerFrance
-
OmicoHoffmann-La Roche; The George Institute for Global Health, AustraliaRecruitingSolid Tumor, AdultAustralia
-
Hoffmann-La RocheRecruitingCarcinoma, HepatocellularKorea, Republic of, Taiwan, United States, France, Spain, New Zealand, United Kingdom
-
Hoffmann-La RocheChugai PharmaceuticalRecruitingCarcinoma, HepatocellularUnited States, Canada, Korea, Republic of, Taiwan, Brazil, Belgium, China, Japan, New Zealand, Singapore, Mexico, Spain, Germany, Poland, Thailand, France, Turkey, Italy, Puerto Rico, Hong Kong, South Africa, Côte D'Ivoire
-
Institut für Klinische Krebsforschung IKF GmbH...Roche Pharma AG; Thoraxklinik-Heidelberg gGmbHRecruitingNon-small Cell Lung CancerGermany
-
Hoffmann-La RocheRecruitingRenal Cell CarcinomaKorea, Republic of, United States, China, Spain, Germany, France, United Kingdom, Poland, Australia
-
Alliance Foundation Trials, LLC.Genentech, Inc.Recruiting
-
Liza Villaruz, MDGenentech, Inc.RecruitingNon-small Cell Lung CancerUnited States
-
National Taiwan University HospitalRecruitingLocally Advanced Esophageal Squamous Cell CarcinomaTaiwan
-
National Cancer Institute (NCI)RecruitingAdvanced Rare Malignant Solid Neoplasm | Rare Malignant Solid Neoplasm | Refractory Rare Malignant Solid NeoplasmUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.RecruitingSquamous Cell Carcinoma | Oral Cavity Squamous Cell CarcinomaUnited States
-
Hoffmann-La RocheRecruitingPD-L1-selected Solid TumorsKorea, Republic of, United States, Spain, Taiwan, Turkey, Greece, Canada, Croatia, Serbia, Mexico, Cyprus, Georgia
-
Hoffmann-La RocheRecruitingUrothelial CancerKorea, Republic of, United States, Brazil, China, France, Germany, Mexico, Poland, Denmark, Turkey, Australia, Greece, Spain, United Kingdom, Italy
-
University Medical Center GroningenRecruitingMelanoma | Head and Neck Neoplasms | MSI-H CancerNetherlands
-
M.D. Anderson Cancer CenterRecruitingMetastatic MalignancyUnited States
-
National Cancer Institute (NCI)RecruitingMalignant Solid Neoplasm | Rhabdoid Tumor | Refractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Rhabdoid Tumor | Refractory Rhabdoid Tumor | Epithelioid Sarcoma | Kidney Medullary Carcinoma | Atypical Teratoid/Rhabdoid Tumor | Poorly Differentiated Chordoma | Recurrent Atypical... and other conditionsUnited States, Australia, Canada
-
Centre Georges Francois LeclercRecruitingMetastatic Renal Cell Carcinoma | Metastatic Non Small Cell Lung Cancer | Metastatic Head and Neck Cancer | Metastatic Bladder CancerFrance
-
Hoffmann-La RocheRecruitingMelanomaFrance, United States, Netherlands, Italy, Spain, Australia
-
Yonsei UniversityNot yet recruitingNon-small Cell Lung CancerKorea, Republic of
-
Georgetown UniversityGenentech, Inc.RecruitingNon-squamous Non-small-cell Lung CancerUnited States
-
Hoffmann-La RocheRecruitingMetastatic Colorectal CancerUnited States, Korea, Republic of, United Kingdom, Australia, Germany, Spain, Taiwan, Canada, Italy, Poland, Denmark, France
-
Hoffmann-La RocheTempest Therapeutics; Adagene IncRecruitingAdvanced Liver CancersKorea, Republic of, Taiwan, United States, Israel, China, France, New Zealand
-
Alliance Foundation Trials, LLC.Eli Lilly and Company; Pfizer; Genentech, Inc.; Foundation MedicineRecruitingEndometrial CancerUnited States
-
Hoffmann-La RocheGilead Sciences, Inc., GlaxoSmithKline plc, Seattle Genetics and AstellasRecruitingBladder Cancer | Urothelial CarcinomaUnited States, Spain, Korea, Republic of, United Kingdom, Taiwan, France, Greece
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingClinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage II Esophageal Adenocarcinoma AJCC v8 | Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8 | Clinical Stage III Esophageal Adenocarcinoma AJCC v8 | Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8 | Pathologic... and other conditionsUnited States
-
Alain AlgaziGenentech, Inc.RecruitingCarcinoma | Cancer | Head and Neck Cancer | Squamous Cell CarcinomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingClinical Stage III Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Pathologic Stage IIID Cutaneous Melanoma AJCC v8 | Pathologic Stage III Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIA Cutaneous Melanoma...United States
-
Hoffmann-La RocheRecruitingCarcinoma, Non-Small-Cell LungKorea, Republic of, France, Spain, Taiwan, United States, Israel, Australia, United Kingdom
-
Genentech, Inc.Active, not recruitingNon-small Cell Lung CancerUnited States, Spain, Korea, Republic of, Taiwan, France, Serbia
-
Hoffmann-La RocheActive, not recruitingEsophageal Squamous Cell CarcinomaUnited States, France, Spain, Australia, Korea, Republic of, Argentina, Belgium, China, Portugal, Taiwan, Japan, Germany, Poland, Thailand, United Kingdom, Switzerland, Turkey, Russian Federation, Morocco, Greece, Italy, New Zealand, South Africa and more
-
Hoffmann-La RocheActive, not recruitingSquamous Cell Carcinoma of Head and NeckUnited States, Korea, Republic of, United Kingdom, Czechia, New Zealand, France, Spain, Greece, Thailand, Taiwan, Hungary, Italy, Poland
-
Hoffmann-La RocheActive, not recruitingSmall Cell Lung CancerTaiwan, United States, Hungary, Korea, Republic of, Belgium, United Kingdom, Spain, Brazil, Germany, Poland, Australia, Singapore, Italy, Switzerland, Turkey, Japan, Netherlands, Austria, Greece, Czechia, New Zealand, Russian Federation and more
-
Hoffmann-La RocheActive, not recruitingNon-Small Cell Lung CancerHungary, Korea, Republic of, Australia, Spain, China, Denmark, Italy, Germany, Mexico, Poland, United States, Brazil, Peru, Thailand, Serbia, Switzerland, Japan, Turkey, Netherlands, Austria, Taiwan, Russian Federation, Ukraine, Greece
-
Hoffmann-La RocheActive, not recruitingNon-Small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, Spain, Switzerland, Australia
-
Hoffmann-La RocheActive, not recruiting
-
SCRI Development Innovations, LLCGenentech, Inc.Active, not recruitingNon-Small Cell Lung Cancer | Solid TumorUnited States
-
Hoffmann-La RocheActive, not recruitingGastric and Gastroesophageal Junction CarcinomaChina
-
Hoffmann-La RocheActive, not recruitingRectal Cancer | Rectal NeoplasmsChina
-
Hoffmann-La RocheActive, not recruitingSquamous Cell Carcinoma of the Head and NeckFrance, United States, Israel, Korea, Republic of, Australia
-
Hoffmann-La RocheTerminatedStomach Neoplasms | Gastric Cancer | Gastroesophageal Junction AdenocarcinomaChina
-
Genentech, Inc.CompletedAdvanced Unresectable or Metastatic Solid MalignancyUnited States
-
Hoffmann-La RocheCompletedNon-Hodgkin Lymphoma, Follicular LymphomaUnited Kingdom, Belgium, United States, Australia, Canada, Germany
-
Genentech, Inc.Active, not recruitingAdvanced/Metastatic TumorsSpain, United States, Korea, Republic of, Australia, France, Japan, Canada
-
Hoffmann-La RocheActive, not recruitingNon-small Cell Lung Cancer (NSCLC)United States, Belgium, Korea, Republic of, Canada, China, Denmark, Spain, Thailand, United Kingdom, Taiwan, Brazil, Germany, Mexico, Italy, Switzerland, Hong Kong, Japan, France, Turkey, New Zealand, Kenya, Poland
-
Hoffmann-La RocheActive, not recruitingNon-small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, United Kingdom, Australia, Belgium, Brazil, Canada, China, Portugal, Spain, France, Germany, Poland, Hong Kong, Israel, Thailand, Turkey, Japan, Austria, Hungary, Italy, Taiwan, Netherlands, Greece, New... and more
-
Hoffmann-La RocheActive, not recruitingPancreatic AdenocarcinomaUnited States, Spain, Korea, Republic of, Germany, Japan